Therapy News and Research

RSS

Transoma Medical commences enrollment in its COMPLIANCE atrial fibrillation clinical trial

Transoma Medical, Inc., manufacturer of Sleuth AT™, the only wireless, automated implantable cardiac monitoring system with programmable and frequent electrocardiogram (ECG) sampling, announced today the first enrollment and implant in the COMPLIANCE trial, a long-term study to compare external event recorders with implantable monitors in patients who have been prescribed catheter ablation therapy for atrial fibrillation (AF) at risk of post-procedure AF recurrence.

23 Sep 2009

Patient recruitment completed for crucial glioblastoma study

MagForce Nanotechnologies AG (FWB:MF6) has successfully completed patient recruitment for its study on recurrent glioblastoma, which is of critical importance for demonstrating the efficacy of its proprietary Nano-Cancer® therapy.

23 Sep 2009

Abiomed announces new data from its USpella IRB registry of Impella 2.5 patients

Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced new clinical data from USpella, the first U.S. multicenter registry of Impella 2.5 patients evaluating the safety and feasibility of left ventricular support with the Impella 2.5 during high-risk percutaneous coronary intervention (PCI) and treatment of acute myocardial infarction (AMI).

23 Sep 2009

Obesity can increase cancer incidence in leukemic children

Obesity is an important factor contributing to chemotherapy resistance and increasing relapse rates among children with leukemia, according to recent findings published online first in Cancer Research, a journal of the American Association for Cancer Research.

23 Sep 2009

Travel Force Staffing's rehabilitation jobs search tool for healthcare professionals

Leading travel therapy recruitment firm, Travel Force Staffing, provides specialized allied healthcare staffing services to hospitals, clinics, managed care and skilled nursing facilities nationwide.

22 Sep 2009

Narrative exposure therapy is effective for traumatized survivors

A group of German investigators performed a controlled study on psychological help for Rwanda orphans of war. Twenty-six orphans (originally 27) who presented with posttraumatic stress disorder (PTSD) at first assessment continued to meet a PTSD DSM-IV diagnosis 6 months after their initial assessment.

22 Sep 2009

French multicenter study investigates the role of psychotherapy in BPD

A French multicenter study headed by Jean Cottraux (Lyon) has investigated the role of psychotherapy in borderline personality disorder.

22 Sep 2009

Cancer Research UK invests £16 million in new Drug Discovery Programes at Manchester and Glasgow

CANCER RESEARCH UK is set to extend its drug discovery effort by investing up to £16 million in two new Drug Discovery Programmes at the Paterson Institute for Cancer Research in Manchester and the Beatson Institute for Cancer Research in Glasgow.

22 Sep 2009

Study reveals effectiveness of targeted heat therapy in addition to chemotherapy

Patients with soft-tissue sarcomas at high risk of spreading were 30% more likely to be alive and cancer free almost three years after starting treatment if their tumours were heated at the time they received chemotherapy, according to new research. The finding bolsters the case for intensifying exploration of the strategy in other types of cancer.

22 Sep 2009

Hormone therapy for treating prostate cancer is linked to heart problems

Berlin, Germany: New research has found that hormone therapy used to treat men with advanced prostate cancer is associated with an increased chance of developing various heart problems. Some choices of therapy appear, however, to be less risky than others.

22 Sep 2009

Researchers to present results of HORIZONS-AMI trial at TCT scientific symposium

Two subset analyses from the landmark HORIZONS-AMI trial show that the anticoagulant bivalirudin lowers major bleeding and cardiac death versus the combination of heparin and a GP IIb/IIIa inhibitor in patients with ST-segment myocardial infarction (STEMI) who have disease of the left anterior descending artery (LAD), while in STEMI patients at highest risk for death, bivalirudin also confers the greatest mortality benefit.

22 Sep 2009

StemCells to take part in international networking event

StemCells, Inc. (NASDAQ:STEM) announced today its participation in the 2009 World Stem Cell Summit to be held September 21 – 23 in Baltimore, Maryland.

22 Sep 2009

New sirolimus-eluting stent shows greater neointimal suppression than PES

A new type of sirolimus-eluting stent (SES) successfully showed significantly greater neointimal suppression than the paclitaxel-eluting stent (PES) with greater vessel wall integrity surrounding the stent, confirming the finding of superiority of the SES over the PES stent for the trial's primary endpoint of in-stent late loss.

22 Sep 2009

IRSF announces funding of new clinical study with disease-modifying therapy treatment for Rett syndrome

Today, the International Rett Syndrome Foundation announced that it will provide $200,000 in 2009 to support a newly proposed clinical trial with a growth-factor based treatment for Rett Syndrome. The study will be carried out by a team of clinical trials specialists at the Boston Children's Hospital, led by Dr. Omar Khwaja MD, PhD and will be the first potentially disease modifying therapy ever to be tested in Rett syndrome patients.

22 Sep 2009

CSL Behring offers new dosage strength of Helixate FS in U.S.

Hemophilia A patients who require high doses of Helixate® FS, Antihemophilic Factor (Recombinant), can now benefit from greater convenience in administering their treatment, thanks to a new 3000 IU (international unit) dosage strength. CSL Behring announced today that this new dosage strength is available in the U.S., allowing many patients to reduce reconstitution time by eliminating the need to mix and pool multiple vials of Helixate FS.

22 Sep 2009

Winners of "Passion & Results" Award announced by Instrumentation Laboratory

Instrumentation Laboratory (IL) today announced the three recipients of their "Passion & Results" Award. The winners were presented with their awards by IL during ceremonies at the Congress for the International Society on Thrombosis and Haemostasis (ISTH) held in Boston, MA, July 11-16 and at the Annual Meeting for the American Association for Clinical Chemistry (AACC), in Chicago, IL, July 19-23.

22 Sep 2009

Amgen announces Phase 3 results evaluating Vectibix in combination with FOLFIRI chemotherapy

Amgen (Nasdaq: AMGN) today announced detailed results from the Phase 3 '181' trial evaluating Vectibix((R)) (panitumumab) in combination with FOLFIRI (an irinotecan based chemotherapy), as a second-line treatment for metastatic colorectal cancer (mCRC). In this trial, Vectibix significantly improved progression-free survival (PFS) in patients with KRAS wild-type mCRC.

22 Sep 2009

Moses Cone Health System installs TomoTherapy cancer treatment system

TomoTherapy Incorporated announced today that Moses Cone Health System has installed North Carolina's first TomoTherapy® cancer treatment system at the Moses Cone Regional Cancer Center in Greensboro, N.C.

22 Sep 2009

Barbershop singing helps cancer-survivor

For Marguerite Paustenbach, her secret weapon in the fight against breast cancer turned out to be her strong faith and love for barbershop singing. Paustenbach is a member of Village Vocal Chords, a Chicago-based barbershop singing group that’s part of Harmony, Inc., an all women’s barbershop singing organization currently celebrating its 50th anniversary.

22 Sep 2009

Mild exercises for the bed-bound patients helps to combat muscle wasting

Critical care experts at Johns Hopkins are reporting initial success in boosting recovery and combating muscle wasting among critically ill, mostly bed-bound patients using any one of a trio of mild physical therapy exercises during their stays in the intensive care unit (ICU).

22 Sep 2009

Therapy News and Research

Transoma Medical commences enrollment in its COMPLIANCE atrial fibrillation clinical trial

Patient recruitment completed for crucial glioblastoma study

Abiomed announces new data from its USpella IRB registry of Impella 2.5 patients

Obesity can increase cancer incidence in leukemic children

Travel Force Staffing's rehabilitation jobs search tool for healthcare professionals

Narrative exposure therapy is effective for traumatized survivors

French multicenter study investigates the role of psychotherapy in BPD

Cancer Research UK invests £16 million in new Drug Discovery Programes at Manchester and Glasgow

Study reveals effectiveness of targeted heat therapy in addition to chemotherapy

Hormone therapy for treating prostate cancer is linked to heart problems

Researchers to present results of HORIZONS-AMI trial at TCT scientific symposium

StemCells to take part in international networking event

New sirolimus-eluting stent shows greater neointimal suppression than PES

IRSF announces funding of new clinical study with disease-modifying therapy treatment for Rett syndrome

CSL Behring offers new dosage strength of Helixate FS in U.S.

Winners of "Passion & Results" Award announced by Instrumentation Laboratory

Amgen announces Phase 3 results evaluating Vectibix in combination with FOLFIRI chemotherapy

Moses Cone Health System installs TomoTherapy cancer treatment system

Barbershop singing helps cancer-survivor

Mild exercises for the bed-bound patients helps to combat muscle wasting

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News